Latest Market News
Steven Goldstein is based in London and responsible for MarketWatch’s coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington bureau chief, directing MarketWatch’s economic, political and regulatory coverage. Follow Steve on Twitter: @MKTWgoldstein. Source: Marketwatch
Johnson & Johnson JNJ, -0.72% said Thursday that a South African Phase 3 study showed that its a booster shot of its COVID-19 vaccine was 85% effective in preventing COVID-19-related hospitalization. The drug maker said the study, conducted by the South African Medical Research Council, was conducted from mid-November to mid-December, which is after omicron […]
Shares of Kroger Co. KR, +0.27% rose 0.9% in premarket trading Thursday, putting them on track for a fourth-straight gain, after the supermarket operator announced a new $1 billions stock repurchase program. The company said the new program replaces the current program, which had about $157 million remaining. The new program represents roughly 3% of […]
Shares of Royal Caribbean Group RCL, -0.58% jumped 1.7% in morning trading Thursday, after the cruise operator looked to play down the impact of the omicron variant of the coronavirus on cruises, saying the impact on bookings has been less than what was experienced with the delta variant. The company said near-term results will be […]
The seven-day average of COVID-19 cases in the U.S. continued its parabolic climb to 344,543 on Thursday, up from 301,477 on Wednesday, up about four-fold since Dec. 1 and 37% above the January 2021 daily peak of 251,232, according to a New York Times tracker. Hospitalizations also kept climbing, but at a slower pace, as […]
The U.K. Medicines and Healthcare products Regulatory Agency said it’s approved Pfizer’s PFE, +1.11% Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. The regulator last month had approved Merck’s MRK, -0.65% Lagevrio. The regulator said it is too early to know whether […]